Moreover, preclinical and early phase clinical trials have confirmed the therapeutic potential of entero-pancreatic hormone combinations in obesity and/or metabolic complications such as T2D [33]
Pipeline Optionality Adds to the Bull Case Beyond the core GLP-1 franchise, Lillys pipeline is generating momentum across multiple therapeutic areas
The safest way to start treatment is by visiting a medical weight loss clinic or your primary care provider, who can prescribe FDA-approved versions and monitor your progress
The LactMed database, maintained by the National Library of Medicine, now states that tirzepatide is usually undetectable in breastmilk with subcutaneous doses of up to 5 mg and that absorption by the infant is unlikely because it is probably partially destroyed in the infant's gastrointestinal tract and poorly absorbed orally
Pooled data from these three trials showed that rates of HF hospitalization were not significantly different between DPP-4i and placebo, suggesting that the effect may not be a class effect [100, 101]